Last 12 months
Inside the activity.
2 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | SaleCommon Stock | 750 | $548.24 | $411,178.58 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 9 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,064 F5 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F9 · price: This transaction was executed in multiple trades at prices ranging from $547.80 to $548.65. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | SaleCommon Stock | 550 | $547.35 | $301,040.41 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 8 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,814 F5 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $546.745 to $547.740. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | SaleCommon Stock | 50 | $543.66 | $27,183.00 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 7 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,364 F5 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | SaleCommon Stock | 200 | $542.83 | $108,566.00 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 6 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,414 F5 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $542.55 to $543.40. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | SaleCommon Stock | 273 | $541.33 | $147,782.27 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 5 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,614 F5 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $541.27 to $541.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | SaleCommon Stock | 15 | $541.76 | $8,126.40 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 4 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,887 F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | SaleCommon Stock | 1,248 | $541.36 | $675,617.28 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 3 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,902 F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | OtherCommon Stock | 2,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,150 F1 · shares: Shares were transferred from direct ownership to ownership under the Balo Family Trust upon vesting of previously awarded restricted stock units. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:19 UTC | OtherCommon Stock | 2,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000223 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,056 F1 · shares: Shares were transferred from direct ownership to ownership under the Balo Family Trust upon vesting of previously awarded restricted stock units. F2 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
|
| September 09, 2021 Filed Sep 14, 2021 00:01 UTC |
Shrishrimal SumiSVP Chief Risk Officer
|
SaleCommon Stock | 5 | $542.46 | $2,712.30 |
DisclosureSEC source: 0001093557-21-000219 · edgardoc.xml · nonDerivative · entry 2 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,234 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,749 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:01 UTC |
Shrishrimal SumiSVP Chief Risk Officer
|
SaleCommon Stock | 402 | $541.36 | $217,626.72 |
DisclosureSEC source: 0001093557-21-000219 · edgardoc.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,239 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 6,749 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 804 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:01 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 2,982 | $541.36 | $1,614,335.52 |
DisclosureSEC source: 0001093557-21-000218 · edgardoc.xml · nonDerivative · entry 2 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,705 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:01 UTC |
SAYER KEVIN RDirector · Chairman, CEO & President
|
SaleCommon Stock | 35 | $541.27 | $18,944.45 |
DisclosureSEC source: 0001093557-21-000218 · edgardoc.xml · nonDerivative · entry 1 SAYER KEVIN R · CIK 0001286858 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,687 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 36,385 unvested restricted stock units, 13,445 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 16,968 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 5,972 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Patterson ChadEVP, Global Marketing
|
SaleCommon Stock | 4 | $542.02 | $2,168.09 |
DisclosureSEC source: 0001093557-21-000217 · edgardoc.xml · nonDerivative · entry 2 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Patterson ChadEVP, Global Marketing
|
SaleCommon Stock | 287 | $541.36 | $155,370.32 |
DisclosureSEC source: 0001093557-21-000217 · edgardoc.xml · nonDerivative · entry 1 Patterson Chad · CIK 0001850152 · EVP, Global Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,904 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 9,603 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,394 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 575 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 15 | $542.01 | $8,130.13 |
DisclosureSEC source: 0001093557-21-000216 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,822 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 1,248 | $541.36 | $675,617.28 |
DisclosureSEC source: 0001093557-21-000216 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,837 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,673 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Murphy Patrick MichaelEVP, Chief Legal Officer
|
SaleCommon Stock | 12 | $541.76 | $6,501.12 |
DisclosureSEC source: 0001093557-21-000215 · edgardoc.xml · nonDerivative · entry 2 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,254 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Murphy Patrick MichaelEVP, Chief Legal Officer
|
SaleCommon Stock | 975 | $541.36 | $527,826.00 |
DisclosureSEC source: 0001093557-21-000215 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,266 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,461 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,953 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
SaleCommon Stock | 15 | $542.03 | $8,130.42 |
DisclosureSEC source: 0001093557-21-000214 · edgardoc.xml · nonDerivative · entry 2 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,322 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 17,501 unvested restricted stock units, 7,171 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 7,832 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
SaleCommon Stock | 1,248 | $541.36 | $675,617.28 |
DisclosureSEC source: 0001093557-21-000214 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,337 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 17,501 unvested restricted stock units, 7,171 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 7,832 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Flynn Paul REVP, Global Revenue
|
SaleCommon Stock | 9 | $541.76 | $4,875.84 |
DisclosureSEC source: 0001093557-21-000213 · edgardoc.xml · nonDerivative · entry 2 Flynn Paul R · CIK 0001850141 · EVP, Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,554 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 10,928 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 14, 2021 00:00 UTC |
Flynn Paul REVP, Global Revenue
|
SaleCommon Stock | 743 | $541.36 | $402,230.48 |
DisclosureSEC source: 0001093557-21-000213 · edgardoc.xml · nonDerivative · entry 1 Flynn Paul R · CIK 0001850141 · EVP, Global Revenue 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,563 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 10,928 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,916 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 1,378 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 23:59 UTC |
Abbey DonaldEVP Quality and Regulatory Aff
|
SaleCommon Stock | 15 | $542.01 | $8,130.16 |
DisclosureSEC source: 0001093557-21-000212 · edgardoc.xml · nonDerivative · entry 2 Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,674 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,673 restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 23:59 UTC |
Abbey DonaldEVP Quality and Regulatory Aff
|
SaleCommon Stock | 1,248 | $541.36 | $675,617.28 |
DisclosureSEC source: 0001093557-21-000212 · edgardoc.xml · nonDerivative · entry 1 Abbey Donald · CIK 0001534342 · EVP Quality and Regulatory Aff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,689 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 13,673 restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 2,498 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 20:15 UTC |
Blackford Quentin S.Chief Operating Officer
|
SaleCommon Stock | 42 | $546.31 | $22,944.85 |
DisclosureSEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 2 Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,261 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 20:15 UTC |
Blackford Quentin S.Chief Operating Officer
|
SaleCommon Stock | 7,639 | $545.87 | $4,169,900.93 |
DisclosureSEC source: 0001093557-21-000202 · edgardoc.xml · nonDerivative · entry 1 Blackford Quentin S. · CIK 0001612451 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,303 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · balance_after: Included in this number are 19,047 unvested restricted stock units, 7,491 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 8,484 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,072 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| September 07, 2021 Filed Sep 8, 2021 22:54 UTC |
Sylvain Jereme MEVP, Chief Financial Officer
|
SaleCommon Stock | 587 | $545.41 | $320,155.67 |
DisclosureSEC source: 0001093557-21-000200 · edgardoc.xml · nonDerivative · entry 1 Sylvain Jereme M · CIK 0001681267 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,933 F1 · shares: On June 4, 2021, Mr. Sylvain adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sylvain. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 11,837 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 3,654 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 1,608 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 1,274 of which were granted on November 8, 2018 and shall vest through November 8, 2021. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 22:38 UTC |
Murphy Patrick MichaelEVP, Chief Legal Officer
|
SaleCommon Stock | 500 | $517.24 | $258,620.00 |
DisclosureSEC source: 0001093557-21-000199 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,241 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:59 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 604 | $517.96 | $312,846.15 |
DisclosureSEC source: 0001093557-21-000197 · edgardoc.xml · nonDerivative · entry 4 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,085 F1 · shares: On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $517.54 to $517.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:59 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 96 | $516.17 | $49,552.32 |
DisclosureSEC source: 0001093557-21-000197 · edgardoc.xml · nonDerivative · entry 3 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,689 F1 · shares: On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · balance_after: Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:59 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 122 | $515.14 | $62,846.98 |
DisclosureSEC source: 0001093557-21-000197 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,785 F1 · shares: On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $514.745 to $515.340. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 20:59 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 256 | $513.41 | $131,432.83 |
DisclosureSEC source: 0001093557-21-000197 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,907 F1 · shares: On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $513.18 to $513.51. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| August 11, 2021 Filed May 23, 2022 21:04 UTC |
Dahut Karen MDirector
|
OtherCommon Stock | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-22-000116 · edgardoc.xml · nonDerivative · entry 4 Dahut Karen M · CIK 0001533450 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 387 F1 · shares: Shares were transferred from direct ownership to ownership under the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, upon vesting of previously awarded restricted stock units. F4 · balance_after: Shares are held by the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, with respect to which the reporting person is a trustee. Read SEC document |
| August 11, 2021 Filed May 23, 2022 21:04 UTC |
Dahut Karen MDirector
|
OtherCommon Stock | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-22-000116 · edgardoc.xml · nonDerivative · entry 1 Dahut Karen M · CIK 0001533450 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,691 F1 · shares: Shares were transferred from direct ownership to ownership under the WILLIAM L DAHUT, JR TRUST & KAREN M DAHUT TRUST Dated 6/14/2005, upon vesting of previously awarded restricted stock units. Read SEC document |
| August 04, 2021 Filed Sep 14, 2021 00:19 UTC |
Selvaraj Shelly RamasamySVP Information Technology
|
GiftCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001093557-21-000224 · edgardoc.xml · nonDerivative · entry 1 Selvaraj Shelly Ramasamy · CIK 0001805707 · SVP Information Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,886 F1 · shares: This transaction represents a gift of securities made by the reporting person. This is not a market transaction, thus no price has been reported. Transferor retains no beneficial or voting interest in the transferred shares. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 00:36 UTC | SaleCommon Stock | 349 | $519.92 | $181,451.87 |
DisclosureSEC source: 0001093557-21-000195 · edgardoc.xml · nonDerivative · entry 8 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 10,652 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F10 · price: This transaction was executed in multiple trades at prices ranging from $519.64 to $520.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| August 03, 2021 Filed Aug 5, 2021 00:36 UTC | SaleCommon Stock | 525 | $519.24 | $272,598.48 |
DisclosureSEC source: 0001093557-21-000195 · edgardoc.xml · nonDerivative · entry 7 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,001 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F9 · price: This transaction was executed in multiple trades at prices ranging from $518.60 to $519.50. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| August 03, 2021 Filed Aug 5, 2021 00:36 UTC | SaleCommon Stock | 200 | $518.06 | $103,611.32 |
DisclosureSEC source: 0001093557-21-000195 · edgardoc.xml · nonDerivative · entry 6 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,526 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F8 · price: This transaction was executed in multiple trades at prices ranging from $517.600 to $518.515. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| August 03, 2021 Filed Aug 5, 2021 00:36 UTC | SaleCommon Stock | 200 | $516.72 | $103,344.50 |
DisclosureSEC source: 0001093557-21-000195 · edgardoc.xml · nonDerivative · entry 5 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,726 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F7 · price: This transaction was executed in multiple trades at prices ranging from $516.425 to $517.020. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| August 03, 2021 Filed Aug 5, 2021 00:36 UTC | SaleCommon Stock | 300 | $515.33 | $154,598.01 |
DisclosureSEC source: 0001093557-21-000195 · edgardoc.xml · nonDerivative · entry 4 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 11,926 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $515.00 to $515.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| August 03, 2021 Filed Aug 5, 2021 00:36 UTC | SaleCommon Stock | 300 | $514.18 | $154,253.13 |
DisclosureSEC source: 0001093557-21-000195 · edgardoc.xml · nonDerivative · entry 3 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,226 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F5 · price: This transaction was executed in multiple trades at prices ranging from $513.59 to $514.43. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| August 03, 2021 Filed Aug 5, 2021 00:36 UTC | SaleCommon Stock | 200 | $512.83 | $102,565.50 |
DisclosureSEC source: 0001093557-21-000195 · edgardoc.xml · nonDerivative · entry 2 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,526 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F4 · price: This transaction was executed in multiple trades at prices ranging from $512.46 to $513.39. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| August 03, 2021 Filed Aug 5, 2021 00:36 UTC | SaleCommon Stock | 683 | $512.19 | $349,823.86 |
DisclosureSEC source: 0001093557-21-000195 · edgardoc.xml · nonDerivative · entry 1 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 12,726 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $511.45 to $512.36. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
|
| July 30, 2021 Filed Aug 2, 2021 22:19 UTC |
Leach Jacob StevenEVP Chief Technology Officer
|
SaleCommon Stock | 12,087 | $476.70 | $5,761,872.90 |
DisclosureSEC source: 0001093557-21-000193 · edgardoc.xml · nonDerivative · entry 1 Leach Jacob Steven · CIK 0001700255 · EVP Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,554 F1 · shares: On March 5, 2021, the reporting person adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Leach. The sale of shares set forth above were pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 19,999 unvested restricted stock units, 7,171 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 7,832 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| July 26, 2021 Filed Jul 27, 2021 22:04 UTC |
Murphy Patrick MichaelEVP, Chief Legal Officer
|
SaleCommon Stock | 500 | $458.79 | $229,395.00 |
DisclosureSEC source: 0001093557-21-000183 · edgardoc.xml · nonDerivative · entry 1 Murphy Patrick Michael · CIK 0001692785 · EVP, Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,741 F1 · shares: On August 28, 2020, Mr. Murphy adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Murphy. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 15,413 unvested restricted stock units, 5,634 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 3,905 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| July 23, 2021 Filed Jul 27, 2021 22:03 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 800 | $452.65 | $362,120.00 |
DisclosureSEC source: 0001093557-21-000182 · edgardoc.xml · nonDerivative · entry 2 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,163 F1 · shares: On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F3 · balance_after: Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| July 23, 2021 Filed Jul 27, 2021 22:03 UTC |
Pacelli Steven RobertManaging Dir., Dexcom Ventures
|
SaleCommon Stock | 279 | $450.82 | $125,777.41 |
DisclosureSEC source: 0001093557-21-000182 · edgardoc.xml · nonDerivative · entry 1 Pacelli Steven Robert · CIK 0001359098 · Managing Dir., Dexcom Ventures 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,963 F1 · shares: On June 15, 2020, Mr. Pacelli adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Pacelli. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $450.70 to $450.96. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F3 · balance_after: Included in this number are 16,171 unvested restricted stock units, 5,301 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 5,874 of which were granted on March 8, 2020 and shall vest through March 8, 2023, and 4,996 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| July 16, 2021 Filed Jul 17, 2021 00:40 UTC |
Shrishrimal SumiSVP Chief Risk Officer
|
SaleCommon Stock | 400 | $450.00 | $180,000.00 |
DisclosureSEC source: 0001093557-21-000179 · edgardoc.xml · nonDerivative · entry 1 Shrishrimal Sumi · CIK 0001850687 · SVP Chief Risk Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,586 F1 · shares: On November 25, 2020, Ms. Shrishrimal adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Shrishrimal. The shares set forth above were sold pursuant to the 10b5-1 Plan. F2 · balance_after: Included in this number are 7,553 unvested restricted stock units, 3,073 of which were granted on March 8, 2021 and shall vest through March 8, 2024, 2,872 of which were granted on March 8, 2020 and shall vest through March 8, 2023 and 1,608 of which were granted on March 8, 2019 and shall vest through March 8, 2022. Read SEC document |
| July 06, 2021 Filed Jul 8, 2021 23:45 UTC | SaleCommon Stock | 286 | $432.05 | $123,565.70 |
DisclosureSEC source: 0001093557-21-000177 · edgardoc.xml · nonDerivative · entry 4 Balo Andrew K · CIK 0001323190 · * 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 13,409 F1 · shares: On March 5, 2021, Mr. Balo adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Balo. The shares set forth above were sold pursuant to the 10b5-1 Plan. F6 · price: This transaction was executed in multiple trades at prices ranging from $431.455 to $432.050. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issurer full information regarding the number of shares and prices at which the transactions were effected. F3 · ownership.nature: Shares are held by the Balo Family Trust U/A/D 4/6/2006, with respect to which the reporting person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.